Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Turk J Vasc Surg. 2020; 29(1): 7-12


Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up

Görkem Yiğit, Mehmet Cahit Sarıcaoğlu, Ferit Çetinkaya, Anıl Özen, Hakkı Zafer İşcan.




Abstract

Objectives: This study aims to present our mid-term experience of treating chronic iliac or femoral total occlusions via percutaneous
transluminal angioplasty (PTA).
Patients and methods: Between January 2017 and August 2019, this single-center, retrospective study included 45 patients (40 males,
5 females; median age 60 years; range, 33 to 81 years) who underwent PTA due to chronic total occlusion.
Results: Of the patients, eight had iliac and 37 had superficial femoral artery occlusion. The technical success rate was 95.5% with a mean
follow-up period 17.2±0.4 months. Bail-out stenting was required in 10 (22.2%) of the lesions and only seven patients (15.5%) needed
percutaneous reintervention at the end of follow-up. Following endovascular interventions, one patient (2.2%) developed seroma, while two
(4.4%) developed infections and one (2.2.%) developed a pseudoaneurysm of the femoral artery. Three patients (6.6%) underwent femoropopliteal bypass. A total of 42 patients completed the follow-up. The Kaplan-Meier analysis revealed a primary patency rate of 83.3% and
freedom from reintervention of 95.2% during 17-month follow-up.
Conclusion: The endovascular treatment strategy of chronic total occlusions of the iliac and femoral arteries is acceptable with less morbidity
and good patency rates. Cardiovascular surgeons should be encouraged in the field of endovascular treatment of peripheral arterial disease
including chronic total occlusions.

Key words: Endovascular treatment, iliac artery, occlusion, peripheral arterial disease.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.